Clinical Trials on Bone Loss, Age-Related

Total 3705 results

David M. Brown, M.D.
Regeneron Pharmaceuticals

Completed

Study for Recalcitrant Age Related Macular Degeneration (TURF)

Age Related Macular Degeneration

United States
Association for Innovation and Biomedical Research...

Completed

Life Style and Food Habits Questionnaire in the Portuguese Population Aged 55 or More

Age Related Macular Degeneration

Portugal
Retina Center, Minnesota
Genentech, Inc.

Completed

ERG/EOG Study in AMD Patients Treated With Ranibizumab (FVF4154s)

Age-Related Macular Degeneration

United States
Sequenom, Inc.
Center for Eye Research and Education

Completed

Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients (EVERGREEN)

Age Related Macular Degeneration

United States
Johann Wolfgang Goethe University Hospital

Completed

Combined Therapy in Age-Related Macular Degeneration (ARMD)

Age-Related Macular Degeneration

Germany
Forsight Vision4

Withdrawn

Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD

Age-Related Macular Degeneration

Israel
Progen Pharmaceuticals

Completed

Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD

Age Related Macular Degeneration

United States, Mexico, Russian Federation
University of Jena

Completed

Effects of Xanthophylls on Optical Density

Age-Related Macular Degeneration

Germany
Illinois Retina Associates
Novartis Pharmaceuticals

Completed

Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment (CLOVER)

Age-Related Macular Degeneration

United States
CoMentis

Completed

Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGF

Age-Related Macular Degeneration
Notal Vision Ltd.

Completed

Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment (AMD)

Age-Related Macular Degeneration

United States
Rudolf Foundation Clinic

Unknown

Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration

Age-Related Macular Degeneration

Austria
Maastricht University Medical Center
Cognis Deutschland GmbH & Co. KG

Completed

The Influence of Lutein Supplements on Age-related Macular Degeneration

Age-Related Macular Degeneration

Netherlands, United Kingdom
Notal Vision Ltd.

Completed

Usability of the PreView PHP for Home Use in Intermediate AMD Patients

Age Related Macular Degeneration

Israel
Weill Medical College of Cornell University

Completed

High-Resolution Ultrasound Imaging of the Retina and Choroid for Detection on Age Related Macular Degeneration

Age Related Macular Degeneration

United States
Rudolf Foundation Clinic

Completed

Retaane® in Age-Related Macular Degeneration

Age Related Macular Degeneration
Oregon Health and Science University

Completed

Non-exudative Age-related Macular Degeneration (NEAMD)

Non-exudative Age-related Macular Degeneration

United States
Tufts University

Active, not recruiting

Comparing the Efficacy and Morbidity of Two Vertical Ridge Augmentation Techniques

Vertical Alveolar Bone Loss

United States
Mansoura University

Completed

Clinical Evaluation of RTX Locator Attachments for Implant-supported Mandibular Complete Overdenture

Vertical Alveolar Bone Loss

Egypt
University of Pittsburgh

Completed

Association Between Light Spectrum and Survival After Cataract Surgery

Glaucoma | Cataract | Age Related Macular Degeneration | Age-related Cataract | Circadian Rhythm Disorders

United States
Mansoura University

Not yet recruiting

Immediate Dental Implants in The Upper Anterior Region

Alveolar Bone Resorption | Teeth Loss

Egypt
University of California, Los Angeles
National Eye Institute (NEI); University of Pittsburgh; Jules Stein Eye Institute

Active, not recruiting

GARM II: A Study on the Genetics of Age-related Maculopathy

Age-related Macular Degeneration | Age-related Maculopathy

United States
VA Office of Research and Development

Recruiting

Active AMD Study to Improve Function in Veterans

Age Related Macular Degeneration (AMD)

United States
Oslo University Hospital

Not yet recruiting

Photobiomodulation for Dry Age Related Macula Degeneration

Age-Related Macular Degeneration | Photobiomodulation
Shin Kong Wu Ho-Su Memorial Hospital

Recruiting

Maximum Treatment Interval With Aflibercept T&E

Neovascular Age-related Macular Degeneration

Taiwan
Novartis Pharmaceuticals

Recruiting

Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting

Neovascular Age-related Macular Degeneration

United Arab Emirates
Berner Augenklinik
medignition AG

Enrolling by invitation

Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD (SPARROW)

Wet Age-related Macular Degeneration

Switzerland
Shanghai Biomabs Pharmaceutical Co., Ltd.

Completed

Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD

Wet Age-related Macular Degeneration

China
Novartis Pharmaceuticals

Completed

Treatment Patterns With Brolucizumab in Germany - a Retrospective Cohort Study Based on Longitudinal Prescription Data: REALIZE Study

Neovascular Age-related Macular Degeneration

Portugal
Michel Giunta
Bayer

Active, not recruiting

Treat and Extend Analysis Trial With Aflibercept in Wet-AMD

Wet Age-related Macular Degeneration

Canada
Frank G. Holz
Radboud University Medical Center; Bayer; Hoffmann-La Roche; Novartis Pharmaceuticals and other collaborators

Active, not recruiting

Development of Novel Clinical Endpoints in Intermediate AMD (MACUSTAR)

Age Related Macular Degeneration (AMD)

Germany, Italy, Netherlands, United Kingdom, France, Portugal, Denmark
Qilu Pharmaceutical Co., Ltd.

Completed

A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Wet Age-related Macular Degeneration

China
Novartis Pharmaceuticals

Completed

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)

Age-related Macular Degeneration (AMD)

United States
Novartis Pharmaceuticals

Completed

Evaluation of Number of Patient Eyes That Remained on or Switched to Anti-VEGF Treatment After Initiation of Broluciumab

Age-related Macular Degeneration (AMD)

United States
Bioeq GmbH

Completed

Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration (COLUMBUS-AMD)

Age-related Macular Degeneration (AMD)

France, Italy, Poland, Russian Federation, Spain, United Kingdom, Germany, Hungary, Ukraine, Austria, Czechia, Israel
i-Lumen Scientific, Inc.

Withdrawn

Microcurrent Stimulation for Dry Age-related Macular Degeneration (i-SIGHT)

Dry Age-related Macular Degeneration
Alkahest, Inc.

Completed

Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration

Wet Age-related Macular Degeneration

Hungary
Alcon, a Novartis Company

Completed

LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration

Exudative Age-Related Macular Degeneration

United States
Tennessee Retina
Regeneron Pharmaceuticals

Unknown

Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept (TRISTAR)

Neovascular Age-related Macular Degeneration

United States
Chinese Academy of Sciences
The First Affiliated Hospital of Zhengzhou University

Unknown

Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells

Dry Age-related Macular Degeneration

China
CHA University

Unknown

The Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD

Dry Age Related Macular Degeneration

Korea, Republic of
Maisonneuve-Rosemont Hospital
Novartis; Foundation Fighting Blindness; Fonds de recherche en ophtalmologie... and other collaborators

Completed

Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD

Exudative Age Related Macular Degeneration

Canada
Novartis Pharmaceuticals

Terminated

A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics

Wet Age-related Macular Degeneration

United Kingdom
PanOptica, Inc.

Completed

Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD

Age-Related Macular Degeneration (AMD)

United States
Palmetto Retina Center, LLC

Unknown

Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910 (RANGE)

Exudative Age-related Macular Degeneration

United States
Ohr Pharmaceutical Inc.

Completed

Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)

Neovascular Age Related Macular Degeneration

United States
Allergan
Molecular Partners AG

Terminated

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

Wet Age-Related Macular Degeneration

Switzerland, France, Czech Republic
Lawson Health Research Institute

Completed

Intravitreal Injection Anesthesia - Comparison of Different Topical Agents

Age-Related Macular Degeneration (AMD)

Canada
The Ludwig Boltzmann Institute of Retinology and...

Completed

The Spectralis-Cirrus Study

Exudative Age Related Macular Degeneration

Austria
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Assessment of Age-related Hearing Loss in HIV-1 Patients (HELO)

HIV Seropositivity

France

Clinical Trials on Bone Loss, Age-Related

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations